Carson Wealth (CWM LLC)’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,425
| Closed | -$40K | – | 5808 |
|
|
2025
Q4 | $40K | Sell |
4,425
-14,854
| -77% | -$111K | ﹤0.01% | 3772 |
|
|
2025
Q3 | $60K | Sell |
19,279
-37,866
| -66% | -$100K | ﹤0.01% | 3384 |
|
|
2025
Q2 | $122K | Buy |
57,145
+4,057
| +8% | +$6.55K | ﹤0.01% | 2560 |
|
|
2025
Q1 | $61K | Buy |
53,088
+50,193
| +1,734% | +$86.2K | ﹤0.01% | 2812 |
|
|
2024
Q4 | $6K | Buy |
2,895
+974
| +51% | +$2.21K | ﹤0.01% | 4157 |
|
|
2024
Q3 | $4K | Buy |
1,921
+652
| +51% | +$1.5K | ﹤0.01% | 4222 |
|
|
2024
Q2 | $3K | Buy |
1,269
+597
| +89% | +$2.48K | ﹤0.01% | 4136 |
|
|
2024
Q1 | $4K | Buy |
+672
| New | +$3.07K | ﹤0.01% | 3798 |
|
|
2023
Q4 | – | Sell |
-25
| Closed | -$1K | – | 4547 |
|
|
2023
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 4100 |
|
|
2023
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 4094 |
|
|
2023
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 3956 |
|
|
2022
Q4 | $1K | Buy |
25
+10
| +67% | +$296 | ﹤0.01% | 3873 |
|
|
2022
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 3792 |
|
|
2022
Q2 | $0 | Buy |
+15
| New | +$224 | ﹤0.01% | 4117 |
|
Other funds holding VTYX
Carson Wealth (CWM LLC)'s VTYX Position: Q1 2026 in Review
Carson Wealth (CWM LLC) sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 4,425 shares — an estimated $40K sold.
Carson Wealth (CWM LLC) first reported a position in VTYX in Q2 2022 and held it in 14 quarters. The position peaked at $122K in Q2 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Carson Wealth (CWM LLC) reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Carson Wealth (CWM LLC) sold 4,425 Ventyx Biosciences shares in Q1 2026, an estimated $40K.
- Carson Wealth (CWM LLC) first reported a position in Ventyx Biosciences in Q2 2022 and held it in 14 quarters.
- Carson Wealth (CWM LLC)'s Ventyx Biosciences position peaked at $122K in Q2 2025.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.